GLP-1 Agonists and Emerging Oral Health Concerns

Patients prescribed GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) are increasingly presenting with an adverse effect informally termed “Ozempic teeth.” Although not widely recognised among the most common systemic side effects, the phenomenon is beginning to be reported in dental settings.
